BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 31971869)

  • 1. Biomarkers in Traumatic Spinal Cord Injury-Technical and Clinical Considerations: A Systematic Review.
    Leister I; Haider T; Mattiassich G; Kramer JLK; Linde LD; Pajalic A; Grassner L; Altendorfer B; Resch H; Aschauer-Wallner S; Aigner L
    Neurorehabil Neural Repair; 2020 Feb; 34(2):95-110. PubMed ID: 31971869
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential diagnostic and prognostic value of serum and cerebrospinal fluid biomarkers in traumatic spinal cord injury: A systematic review.
    Yousefifard M; Sarveazad A; Babahajian A; Baikpour M; Shokraneh F; Vaccaro AR; Harrop JS; Fehlings MG; Hosseini M; Rahimi-Movaghar V
    J Neurochem; 2019 May; 149(3):317-330. PubMed ID: 30488446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Value of Serum Levels of GFAP, pNF-H, and NSE Compared With Clinical Findings in Severity Assessment of Human Traumatic Spinal Cord Injury.
    Ahadi R; Khodagholi F; Daneshi A; Vafaei A; Mafi AA; Jorjani M
    Spine (Phila Pa 1976); 2015 Jul; 40(14):E823-30. PubMed ID: 25341992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA Biomarkers in Cerebrospinal Fluid and Serum Reflect Injury Severity in Human Acute Traumatic Spinal Cord Injury.
    Tigchelaar S; Gupta R; Shannon CP; Streijger F; Sinha S; Flibotte S; Rizzuto MA; Street J; Paquette S; Ailon T; Charest-Morin R; Dea N; Fisher C; Dvorak MF; Dhall S; Mac-Thiong JM; Parent S; Bailey C; Christie S; Van Keuren-Jensen K; Nislow C; Kwon BK
    J Neurotrauma; 2019 Aug; 36(15):2358-2371. PubMed ID: 30827169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal Fluid Biomarkers To Stratify Injury Severity and Predict Outcome in Human Traumatic Spinal Cord Injury.
    Kwon BK; Streijger F; Fallah N; Noonan VK; Bélanger LM; Ritchie L; Paquette SJ; Ailon T; Boyd MC; Street J; Fisher CG; Dvorak MF
    J Neurotrauma; 2017 Feb; 34(3):567-580. PubMed ID: 27349274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial fibrillary acidic protein is a robust biomarker in cerebrospinal fluid and peripheral blood after traumatic spinal cord injury: a prospective pilot study.
    Wichmann TO; Kasch H; Dyrskog S; Høy K; Møller BK; Krog J; Hoffmann HJ; Hviid CVB; Rasmussen MM
    Acta Neurochir (Wien); 2023 Jun; 165(6):1417-1425. PubMed ID: 36790588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury.
    Kwon BK; Stammers AM; Belanger LM; Bernardo A; Chan D; Bishop CM; Slobogean GP; Zhang H; Umedaly H; Giffin M; Street J; Boyd MC; Paquette SJ; Fisher CG; Dvorak MF
    J Neurotrauma; 2010 Apr; 27(4):669-82. PubMed ID: 20038240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting Injury Severity and Neurological Recovery after Acute Cervical Spinal Cord Injury: A Comparison of Cerebrospinal Fluid and Magnetic Resonance Imaging Biomarkers.
    Dalkilic T; Fallah N; Noonan VK; Salimi Elizei S; Dong K; Belanger L; Ritchie L; Tsang A; Bourassa-Moreau E; Heran MKS; Paquette SJ; Ailon T; Dea N; Street J; Fisher CG; Dvorak MF; Kwon BK
    J Neurotrauma; 2018 Feb; 35(3):435-445. PubMed ID: 29037121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The developing landscape of diagnostic and prognostic biomarkers for spinal cord injury in cerebrospinal fluid and blood.
    Hulme CH; Brown SJ; Fuller HR; Riddell J; Osman A; Chowdhury J; Kumar N; Johnson WE; Wright KT
    Spinal Cord; 2017 Feb; 55(2):114-125. PubMed ID: 27995945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurochemical biomarkers in spinal cord injury.
    Kwon BK; Bloom O; Wanner IB; Curt A; Schwab JM; Fawcett J; Wang KK
    Spinal Cord; 2019 Oct; 57(10):819-831. PubMed ID: 31273298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible Strategies to Optimize a Biomarker Discovery Approach to Correlate with Neurological Outcome in Patients with Spinal Cord Injury: A Pilot Study.
    Fernández M; Baldassarro VA; Capirossi R; Montevecchi R; Bonavita J; Cescatti M; Giovannini T; Giovannini G; Uneddu M; Giovanni G; Giardino L; Calzà L
    J Neurotrauma; 2020 Feb; 37(3):431-440. PubMed ID: 31215324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid levels of GFAP and pNF-H are elevated in patients with chronic spinal cord injury and neurological deterioration.
    Holmström U; Tsitsopoulos PP; Holtz A; Salci K; Shaw G; Mondello S; Marklund N
    Acta Neurochir (Wien); 2020 Sep; 162(9):2075-2086. PubMed ID: 32588294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Cerebrospinal Fluid and Serum Biomarker Levels and Diagnosis, Injury Severity, and Short-Term Outcomes in Patients with Acute Traumatic Spinal Cord Injury.
    Yang Z; Apiliogullari S; Fu Y; Istanbouli A; Kaur S; Jabbal IS; Moghieb A; Irfan Z; Patterson RL; Kurup M; Morrow L; Cohn M; Zhang Z; Zhu J; Hayes RL; Bramlett HM; Bullock MR; Dietrich WD; Wang MY; Kobeissy F; Wang KW
    Diagnostics (Basel); 2023 May; 13(10):. PubMed ID: 37238298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers for severity of spinal cord injury in the cerebrospinal fluid of rats.
    Lubieniecka JM; Streijger F; Lee JH; Stoynov N; Liu J; Mottus R; Pfeifer T; Kwon BK; Coorssen JR; Foster LJ; Grigliatti TA; Tetzlaff W
    PLoS One; 2011 Apr; 6(4):e19247. PubMed ID: 21559420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal cord injury: a study protocol for a systematic review and meta-analysis of microRNA alterations.
    Tigchelaar S; He Z; Tharin S
    Syst Rev; 2022 Apr; 11(1):61. PubMed ID: 35382886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between injury severity and amyloid β protein levels in serum and cerebrospinal fluid in rats with traumatic spinal cord injury.
    Guo L; Hou J; Zhong J; Liu J; Sun T; Liu H
    Mol Med Rep; 2017 Apr; 15(4):2241-2246. PubMed ID: 28259979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Targeted Proteomics Analysis of Cerebrospinal Fluid after Acute Human Spinal Cord Injury.
    Streijger F; Skinnider MA; Rogalski JC; Balshaw R; Shannon CP; Prudova A; Belanger L; Ritchie L; Tsang A; Christie S; Parent S; Mac-Thiong JM; Bailey C; Urquhart J; Ailon T; Paquette S; Boyd M; Street J; Fisher CG; Dvorak MF; Borchers CH; Foster LJ; Kwon BK
    J Neurotrauma; 2017 Jun; 34(12):2054-2068. PubMed ID: 28276985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural biomarkers in the cerebrospinal fluid within 24 h after a traumatic spinal cord injury: a descriptive analysis of 16 subjects.
    Pouw MH; Kwon BK; Verbeek MM; Vos PE; van Kampen A; Fisher CG; Street J; Paquette SJ; Dvorak MF; Boyd MC; Hosman AJ; van de Meent H
    Spinal Cord; 2014 Jun; 52(6):428-33. PubMed ID: 24710150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers in Spinal Cord Injury: Prognostic Insights and Future Potentials.
    Albayar AA; Roche A; Swiatkowski P; Antar S; Ouda N; Emara E; Smith DH; Ozturk AK; Awad BI
    Front Neurol; 2019; 10():27. PubMed ID: 30761068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers in Spinal Cord Injury: from Prognosis to Treatment.
    Rodrigues LF; Moura-Neto V; E Spohr TCLS
    Mol Neurobiol; 2018 Aug; 55(8):6436-6448. PubMed ID: 29307082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.